![](/images/general/no_picture/200_user.png)
Khoi H Tran
Supervisory Patent Examiner (ID: 6826, Phone: (571)272-6919 , Office: P/3664 )
Most Active Art Unit | 3651 |
Art Unit(s) | 3101, 3664, 3615, 3651 |
Total Applications | 1154 |
Issued Applications | 874 |
Pending Applications | 133 |
Abandoned Applications | 147 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17443757
[patent_doc_number] => 20220064262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => FUSION PROTEINS COMPRISING PDGF AND VEGF BINDING PORTIONS AND METHODS OF USING THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/367027
[patent_app_country] => US
[patent_app_date] => 2021-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27169
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17367027
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/367027 | FUSION PROTEINS COMPRISING PDGF AND VEGF BINDING PORTIONS AND METHODS OF USING THEREOF | Jul 1, 2021 | Pending |
Array
(
[id] => 17258833
[patent_doc_number] => 20210371818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => METHOD FOR INDUCING DIFFERENTIATION OF CORNEAL EPITHELIAL CELLS FROM PLURIPOTENT STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/348174
[patent_app_country] => US
[patent_app_date] => 2021-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9247
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17348174
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/348174 | METHOD FOR INDUCING DIFFERENTIATION OF CORNEAL EPITHELIAL CELLS FROM PLURIPOTENT STEM CELLS | Jun 14, 2021 | Pending |
Array
(
[id] => 17126483
[patent_doc_number] => 20210301251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => METHODS FOR GENERATING AND USING ORGANOIDS AND TISSUE THEREIN
[patent_app_type] => utility
[patent_app_number] => 17/344064
[patent_app_country] => US
[patent_app_date] => 2021-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17344064
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/344064 | METHODS FOR GENERATING AND USING ORGANOIDS AND TISSUE THEREIN | Jun 9, 2021 | Pending |
Array
(
[id] => 17604268
[patent_doc_number] => 11332741
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-05-17
[patent_title] => Compositions and methods for treating leber's hereditary optic neuropathy
[patent_app_type] => utility
[patent_app_number] => 17/320388
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 24971
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17320388
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/320388 | Compositions and methods for treating leber's hereditary optic neuropathy | May 13, 2021 | Issued |
Array
(
[id] => 18995995
[patent_doc_number] => 11912823
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Methods of preparing a poloxamer for use in cell culture medium
[patent_app_type] => utility
[patent_app_number] => 17/319886
[patent_app_country] => US
[patent_app_date] => 2021-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 22570
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 220
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319886
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/319886 | Methods of preparing a poloxamer for use in cell culture medium | May 12, 2021 | Issued |
Array
(
[id] => 17214792
[patent_doc_number] => 20210348129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => NON-DECELLULARIZED PLANT LEAF CULTURES FOR MEAT
[patent_app_type] => utility
[patent_app_number] => 17/317037
[patent_app_country] => US
[patent_app_date] => 2021-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8583
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17317037
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/317037 | NON-DECELLULARIZED PLANT LEAF CULTURES FOR MEAT | May 10, 2021 | Pending |
Array
(
[id] => 17960315
[patent_doc_number] => 20220340895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY
[patent_app_type] => utility
[patent_app_number] => 17/317295
[patent_app_country] => US
[patent_app_date] => 2021-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24683
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17317295
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/317295 | COMPOSITIONS AND METHODS FOR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY | May 10, 2021 | Pending |
Array
(
[id] => 17355410
[patent_doc_number] => 20220016206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => ISOFORM NELL-1 PEPTIDE
[patent_app_type] => utility
[patent_app_number] => 17/315593
[patent_app_country] => US
[patent_app_date] => 2021-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17315593
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/315593 | ISOFORM NELL-1 PEPTIDE | May 9, 2021 | Pending |
Array
(
[id] => 18964417
[patent_doc_number] => 11898169
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Synergistic genome-nonintegrating reprogramming by microRNAs and transcription factors
[patent_app_type] => utility
[patent_app_number] => 17/239059
[patent_app_country] => US
[patent_app_date] => 2021-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 18
[patent_no_of_words] => 11515
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17239059
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/239059 | Synergistic genome-nonintegrating reprogramming by microRNAs and transcription factors | Apr 22, 2021 | Issued |
Array
(
[id] => 16990225
[patent_doc_number] => 20210228645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => METHODS FOR PRODUCING RETINAL TISSUE AND RETINA-RELATED CELL
[patent_app_type] => utility
[patent_app_number] => 17/227497
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15283
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227497
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/227497 | METHODS FOR PRODUCING RETINAL TISSUE AND RETINA-RELATED CELL | Apr 11, 2021 | Pending |
Array
(
[id] => 16961569
[patent_doc_number] => 20210213068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => PLURIPOTENT STEM CELL FOR TREATMENT OF CEREBRAL INFARCTION
[patent_app_type] => utility
[patent_app_number] => 17/219430
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6098
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219430
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/219430 | PLURIPOTENT STEM CELL FOR TREATMENT OF CEREBRAL INFARCTION | Mar 30, 2021 | Pending |
Array
(
[id] => 17814310
[patent_doc_number] => 11419898
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-23
[patent_title] => Combinatorial cancer immunotherapy
[patent_app_type] => utility
[patent_app_number] => 17/219569
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 120
[patent_figures_cnt] => 122
[patent_no_of_words] => 62423
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 329
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219569
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/219569 | Combinatorial cancer immunotherapy | Mar 30, 2021 | Issued |
Array
(
[id] => 17228682
[patent_doc_number] => 20210355238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => NON-HUMAN ANIMALS THAT SELECT FOR LIGHT CHAIN VARIABLE REGIONS THAT BIND ANTIGEN
[patent_app_type] => utility
[patent_app_number] => 17/204253
[patent_app_country] => US
[patent_app_date] => 2021-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54714
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17204253
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/204253 | NON-HUMAN ANIMALS THAT SELECT FOR LIGHT CHAIN VARIABLE REGIONS THAT BIND ANTIGEN | Mar 16, 2021 | Pending |
Array
(
[id] => 16913995
[patent_doc_number] => 20210187087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => TARGETING DNA VACCINES TO B CELLS AS PRIMARY ANTIGEN PRESENTING CELLS
[patent_app_type] => utility
[patent_app_number] => 17/191378
[patent_app_country] => US
[patent_app_date] => 2021-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10173
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 208
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17191378
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/191378 | TARGETING DNA VACCINES TO B CELLS AS PRIMARY ANTIGEN PRESENTING CELLS | Mar 2, 2021 | Pending |
Array
(
[id] => 16913975
[patent_doc_number] => 20210187067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => TREATMENT OF DISEASES INVOLVING DEFICIENCY OF ENPP1 OR ENPP3
[patent_app_type] => utility
[patent_app_number] => 17/178127
[patent_app_country] => US
[patent_app_date] => 2021-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42781
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17178127
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/178127 | TREATMENT OF DISEASES INVOLVING DEFICIENCY OF ENPP1 OR ENPP3 | Feb 16, 2021 | Abandoned |
Array
(
[id] => 16822763
[patent_doc_number] => 20210138056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => NEOEPITOPE VACCINE COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/148324
[patent_app_country] => US
[patent_app_date] => 2021-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17148324
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/148324 | NEOEPITOPE VACCINE COMPOSITIONS AND METHODS OF USE THEREOF | Jan 12, 2021 | Abandoned |
Array
(
[id] => 16977966
[patent_doc_number] => 20210222203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => RXR-ALPHA GENE KNOCKOUT CELL LINE WITH STABLE AND LOW RXR-ALPHA PROTEIN EXPRESSION AND PRODUCTION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/135916
[patent_app_country] => US
[patent_app_date] => 2020-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17135916
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/135916 | RXR-ALPHA GENE KNOCKOUT CELL LINE WITH STABLE AND LOW RXR-ALPHA PROTEIN EXPRESSION AND PRODUCTION METHOD THEREOF | Dec 27, 2020 | Pending |
Array
(
[id] => 16825672
[patent_doc_number] => 20210140965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => CORNEAL ENDOTHELIAL CELL MARKER
[patent_app_type] => utility
[patent_app_number] => 17/133326
[patent_app_country] => US
[patent_app_date] => 2020-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28490
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17133326
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/133326 | CORNEAL ENDOTHELIAL CELL MARKER | Dec 22, 2020 | Pending |
Array
(
[id] => 16760451
[patent_doc_number] => 20210106032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => APPARATUSES AND METHODS FOR PREPARING A COMESTIBLE MEAT PRODUCT
[patent_app_type] => utility
[patent_app_number] => 17/131514
[patent_app_country] => US
[patent_app_date] => 2020-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17131514
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/131514 | Apparatuses and methods for preparing a comestible meat product | Dec 21, 2020 | Issued |
Array
(
[id] => 16760403
[patent_doc_number] => 20210105984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => ADAM6 MICE
[patent_app_type] => utility
[patent_app_number] => 17/129706
[patent_app_country] => US
[patent_app_date] => 2020-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43606
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17129706
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/129706 | ADAM6 MICE | Dec 20, 2020 | Pending |